The court directed the firm to pay Ms Gichuki 10 months’ salary as compensation would be adequate in the circumstances ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common. But a BBC investigation has highlighted ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

The company will publish its Full-Year 2024 financial results on March 26, 2025. On the reporting date, BioVersys will issue a press release at 7:00 AM CET.

GSK plc (NYSE:GSK) specializes in pharmaceuticals, vaccines, and consumer health products, with a strong focus on immunology ...

The study found that N6LS (VH3810109 or VH109), given every four months in combination with already marketed monthly ...

The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

Godrej Agrovet's board approved the acquisition of the remaining 48.06 percent stake in Creamline Dairy Products, which is ...

UK drugmaker GSK is struggling to convince the ... said investors were confident about the company’s ability to commercialise products, but saw its research and development as more of a ...

ViiV Healthcare has announced promising results from two Phase IIa studies of investigational antiretroviral therapies, VH184 ...

Clinical validation of the Azymetric platform is demonstrated by the accelerated approval of Ziihera® (zanidatamab-hrii), a treatment for advanced HER2-positive biliary tract cancer in adults who have ...